NCT07116252

Brief Summary

This study aims to improve the postoperative endodontic outcome by assessing the effect of different irrigants on postoperative endodontic pain and their anti-inflammatory effects.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

2 years

First QC Date

July 5, 2025

Last Update Submit

August 4, 2025

Conditions

Keywords

ClodronateHEBPMMP-9EDTAContinous chelation

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain assessment using Numerical Rating Scale NRS

    Postoperative pain is assessed after 6, 12, 24, 48 hours and 7 days after the first visit using a numerical rating scale NRS where the patient is asked to select the number representing the pain intensity as follow '0' representing no pain and '10' being the worst pain

    Postoperative pain was assessed after 6, 12, 24, 48 hours and 7 days after the first visit using a numerical rating scale NRS

  • MMP-9 levels in periapical tissues using periapical fluid samples using a commercially available ELISA kit

    MMP-9 levels in periapical tissues are quantified using a commercially available ELISA kit applied on the periapical samples that will be collected after the final rinse (S1) and after one week (S2).

    After the final rinse (S1) and after one week (S2).

Study Arms (5)

17% EDTA - sequential chelation

EXPERIMENTAL

Irrigation by 2.5% NaOCl during instrumention and a final rinse by 17% EDTA (sequential chelation protocol)

Procedure: EDTA

9% HEBP - sequential chelation

EXPERIMENTAL

Irrigation by 2.5% NaOCl during instrumention and a final rinse by 9% HEBP (sequential chelation protocol)

Procedure: Etidronate

0.26 M (7.6%) clodronate - sequential chelation

EXPERIMENTAL

Irrigation by 2.5% NaOCl during instrumention and a final rinse by 0.26 M (7.6%) clodronate (sequential chelation protocol)

Procedure: clodronate

2.5% NaOCl + 9% HEBP - continous chelation

EXPERIMENTAL

Irrigation by 2.5% NaOCl + 9% HEBP during instrumention and as final rinse (continous chelation protocol)

Procedure: Etidronic acid /sodium hypochlorite

2.5% NaOCl + 0.26 M (7.6%) clodronate - continuous chelation

EXPERIMENTAL

Irrigation by 2.5% NaOCl + 0.26 M (7.6%) clodronate during instrumention and as final rinse (continous chelation protocol)

Procedure: clodronate + sodium hypochlorite

Interventions

EDTAPROCEDURE

17% EDTA as a final rinse after instrumentaion (sequential chelation)

Also known as: 17% Ethylenediaminetetraacetic Acid.
17% EDTA - sequential chelation
EtidronatePROCEDURE

9% HEBP as a final rinse after instrumentation (sequential chelation)

Also known as: 9% HEBP or HEDP (1-Hydroxyethylidene-1,1-bisphosphonate)
9% HEBP - sequential chelation
clodronatePROCEDURE

0.26 M (7.6%) clodronate as a final rinse after instrumentation (sequential chelation)

Also known as: 0.26 M (7.6%) clodronate or clodronic acid
0.26 M (7.6%) clodronate - sequential chelation

(2.5% NaOCl + 9% HEBP) during instrumentation and as a final rinse after instrumentation (continous chelation)

Also known as: 2.5% NaOCl + 9% HEBP - continous chelation
2.5% NaOCl + 9% HEBP - continous chelation

2.5% NaOCl + 0.26 M (7.6%) clodronate during instrumentation and as a final rinse after instrumentation (continuous chelation)

Also known as: 2.5% NaOCl + 0.26 M (7.6%) clodronate - continuous chelation
2.5% NaOCl + 0.26 M (7.6%) clodronate - continuous chelation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients presenting with a single rooted tooth (maxillary anteriors and mandibular premolars) with closed apex and a single patent canal type I in Vertucci's classification (Vertucci et al., 1974)
  • Having a necrotic pulp and asymptomatic apical periodontitis (periapical lesion).
  • Periapical lesions of endodontic origin with a diameter ranging from 2 to 5mm, having a periapical index score of 4 or 5 (Orstavik, Kerekes and Eriksen, 1986)

You may not qualify if:

  • (i) Patients with pain before treatment (ii) Patients having chronic condition requiring the intake of anti-inflammatory/antibiotic drugs.
  • (iii) Teeth having non-restorable tooth with gross carious lesions, fractures, internal or external root resorption or cracks involving the periodontium.
  • (iv) Root canals in which patency for periapical fluid sampling could not be achieved.
  • (v) immune-compromised patients or patients with complicated systemic diseases, physical disability or psychological problems (vi) patients received antibiotic therapy within the last 3months. (vii) Teeth associated with bone expansion or with a history of endodontic treatment.
  • (viii) Teeth with periodontal pockets deeper than 4mm, with or without concomitant or combined endo-perio communication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry, suez canal university

Ismailia, Egypt

Location

Related Publications (7)

  • La Rosa GRM, Plotino G, Nagendrababu V, Pedulla E. Effectiveness of continuous chelation irrigation protocol in endodontics: a scoping review of laboratory studies. Odontology. 2024 Jan;112(1):1-18. doi: 10.1007/s10266-023-00835-8. Epub 2023 Jul 11.

    PMID: 37433927BACKGROUND
  • Rath PP, Yiu CKY, Matinlinna JP, Kishen A, Neelakantan P. The effects of sequential and continuous chelation on dentin. Dent Mater. 2020 Dec;36(12):1655-1665. doi: 10.1016/j.dental.2020.10.010. Epub 2020 Nov 5.

    PMID: 33162115BACKGROUND
  • Bassam S, El-Ahmar R, Salloum S, Ayoub S. Endodontic postoperative flare-up: An update. Saudi Dent J. 2021 Nov;33(7):386-394. doi: 10.1016/j.sdentj.2021.05.005. Epub 2021 Jun 3.

    PMID: 34803278BACKGROUND
  • Ahmed GM, El-Baz AA, Hashem AA, Shalaan AK. Expression levels of matrix metalloproteinase-9 and gram-negative bacteria in symptomatic and asymptomatic periapical lesions. J Endod. 2013 Apr;39(4):444-8. doi: 10.1016/j.joen.2012.11.009. Epub 2013 Jan 16.

    PMID: 23522533BACKGROUND
  • Zollinger A, Mohn D, Zeltner M, Zehnder M. Short-term storage stability of NaOCl solutions when combined with Dual Rinse HEDP. Int Endod J. 2018 Jun;51(6):691-696. doi: 10.1111/iej.12875. Epub 2017 Dec 5.

    PMID: 29121393BACKGROUND
  • Wright PP, Cooper C, Kahler B, Walsh LJ. From an assessment of multiple chelators, clodronate has potential for use in continuous chelation. Int Endod J. 2020 Jan;53(1):122-134. doi: 10.1111/iej.13213. Epub 2019 Sep 26.

    PMID: 31483863BACKGROUND
  • Ballal NV, Gandhi P, Shenoy PA, Shenoy Belle V, Bhat V, Rechenberg DK, Zehnder M. Safety assessment of an etidronate in a sodium hypochlorite solution: randomized double-blind trial. Int Endod J. 2019 Sep;52(9):1274-1282. doi: 10.1111/iej.13129. Epub 2019 May 13.

    PMID: 30993696BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeInflammation

Interventions

Edetic AcidEtidronic AcidClodronic AcidSodium Hypochlorite

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

EthylenediaminesDiaminesPolyaminesAminesOrganic ChemicalsAcetatesAcids, AcyclicCarboxylic AcidsDiphosphonatesOrganophosphonatesOrganophosphorus CompoundsHypochlorous AcidChlorine CompoundsInorganic ChemicalsOxidesOxygen CompoundsSodium Compounds

Study Officials

  • Dalia Fayyad

    Professor of endodontics, faculty of dentistry, Suez Canal University

    STUDY DIRECTOR
  • Dalia Abdallah

    Associate Professor of endodontics, faculty of dentistry, Suez Canal University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 5 groups with different treatment protocols to assess two parameters
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant lecturer of endodontics

Study Record Dates

First Submitted

July 5, 2025

First Posted

August 11, 2025

Study Start

August 20, 2023

Primary Completion

September 1, 2025

Study Completion

December 1, 2025

Last Updated

August 11, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

study protocol and results

Shared Documents
STUDY PROTOCOL

Locations